RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Vertex’s VX770 Is Poised To Become The First Targeted Therapy To Be Approved In Cystic Fibrosis
Mar 2011 - 4 pages - $500
Marien-Hospital Wesel GmbH - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Englewood Hospital and Medical Center - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Royal United Hospital Bath NHS Trust - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Pulmonary Fibrosis Global Clinical Trials Review, Q4, 2010
Dec 2010 - 52 pages - $1,000
New England Baptist Hospital - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Huntington Memorial Hospital - Strategic SWOT Analysis Review
May 2011 - 15 pages - $250
Liver Fibrosis Global Clinical Trials Review, Q1, 2011
Apr 2011 - 57 pages - $1,000
The Medical Device Market:Spain
Feb 2012 - 98 pages - $1,085
Computer Assisted Radiology and Surgery (CARS) 2009 Conference Review and Analysis
Jul 2009 - 23 pages - $1,000
More Related Market Research Reports >>>

Your selection

Industry sector
Diagnostic del
Nuclear medicine del
Therapeutic target
Hospital and Surgery del
Fibrosis del

Browse By

Development phase
Early Stage
Preclinical
Phase I
Phase I/II
Phase II
Phase III
Phase III/IV
Preregistration
Registered

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us